Chronic / carcinogenicity studies
28-day repeated dose studies
OECD 407 Repeated Dose 28-day Oral Toxicity Study in Rodents
Study Purpose and Introduction:
The objective of this study is to obtain information on the toxic potential of the test item in male and female rats likely to arise from oral repeated exposure to the test item over a 28-Day repeat-dose test period. The test item is administered by gavage or via the diet or drinking water. According to the OECD guideline the report of this study will include results from clinical and functional observations, body weight and food/water consumption measurements, hematology and clinical biochemistry; as well as gross necropsy and histopathology.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 407, “Repeated Dose 28-day Oral Toxicity Study in Rodents” (link: https://www.oecd-ilibrary.org/
OECD 407 Repeated Dose 28-day Oral Toxicity Study in Rodents
Study Purpose and Introduction:
The objective of this study is to obtain information on the toxic potential of the test item in male and female rats likely to arise from oral repeated exposure to the test item over a 28-Day repeat-dose test period. The test item is administered by gavage or via the diet or drinking water. According to the OECD guideline the report of this study will include results from clinical and functional observations, body weight and food/water consumption measurements, hematology and clinical biochemistry; as well as gross necropsy and histopathology.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 407, “Repeated Dose 28-day Oral Toxicity Study in Rodents” (link: https://www.oecd-ilibrary.org/
OECD 410 Repeated Dose Dermal Toxicity: 21/28-day Study
Study Purpose and Introduction:
This study relates to the analysis, via dermal application, of the health hazard of solid or liquid test substance. This method is composed of two tests: the main test and the limit test. The method is based on the repeated application of the substance of interest during one limited period (several hours daily during 21/28 days). The results of this study include: measurements and daily and detailed observations (haematology, clinical biochemistry and urinalysis), as well as gross necropsy and histopathology. A properly conducted 21-day or 28-day study should provide information on the effects of repeated inhalation exposure and can indicate the need for further longer term studies and provide information on the dose levels of the latter.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 410, “Repeated Dose Dermal Toxicity: 21/28-day Study” (link: https://www.oecd-ilibrary.org/
90-day repeated dose studies
OECD 408 Repeated Dose 90-Day Oral Toxicity Study in Rodents
Study Purpose and Introduction:
The objective of this study is to obtain information on the possible health hazards likely to arise from repeated exposure of test item a 90/91-day period of time covering post-weaning maturation and growth well into adulthood. The test compound is administered by gavage or via the diet or drinking water. The study intends to provide information on the major toxic effects, indicate target organs and the possibility of accumulation and an estimate of a no-observed-adverse-effect level (NOAEL) of exposure. Alternatively, this study yields dose related response data that may be used to estimate point of departure for hazard assessment using appropriate modelling methods (e.g., benchmark dose analysis).
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 408, “Repeated Dose 90-Day Oral Toxicity Study in Rodents” (link: https://www.oecd-ilibrary.org/
OECD 408 Repeated Dose 90-Day Oral Toxicity Study in Rodents
Study Purpose and Introduction:
The objective of this study is to obtain information on the possible health hazards likely to arise from repeated exposure of test item a 90/91-day period of time covering post-weaning maturation and growth well into adulthood. The test compound is administered by gavage or via the diet or drinking water. The study intends to provide information on the major toxic effects, indicate target organs and the possibility of accumulation and an estimate of a no-observed-adverse-effect level (NOAEL) of exposure. Alternatively, this study yields dose related response data that may be used to estimate point of departure for hazard assessment using appropriate modelling methods (e.g., benchmark dose analysis).
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 408, “Repeated Dose 90-Day Oral Toxicity Study in Rodents” (link: https://www.oecd-ilibrary.org/
OECD 409 Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents
Study Purpose and Introduction:
This method provides information on health hazard likely to arise from short-term exposure to test substance. The method is based on the repeated oral administration of the substance of interest over a prolonged period (one dose level daily during 90 days). The commonly used non-rodent species is the dog. The test compound is administered in the diet or in the drinking water, by gavage or in capsules. A properly conducted 90-day subchronic test should provide a satisfactory estimation of a no-effect level.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 409, “Repeated Dose 90-Day Oral Toxicity Study in Non-Rodents” (link: https://www.oecd-ilibrary.org/
OECD 411 Subchronic Dermal Toxicity: 90-day Study
Study Purpose and Introduction:
This study relates to the analysis, via dermal application, of the health hazards of solid or liquid test substance. It may be carried out after initial information obtained by acute testing. The commonly used rodent species are the adult rat, rabbit or guinea pig. A properly conducted subchronic test should provide a satisfactory estimation of a non effect level.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 411, “Subchronic Dermal Toxicity: 90-day Study” (link: https://www.oecd-ilibrary.org/
Chronic / carcinogenicity studies
OECD 451 Carcinogenicity Studies
Study Purpose and Introduction:
The objective of a long-term carcinogenicity study is to observe test animals for a major portion of their life span for the development of neoplastic lesions during or after exposure to various doses of a test substance by an appropriate route of administration. The three main routes of administration used in carcinogenicity studies are oral, dermal and inhalation. The choice of the route of administration depends on the physical and chemical characteristics of the test chemical and the predominant route of exposure of humans. The duration of the study will normally be 24 months for rodents.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 451, “Carcinogenicity Studies” (link: https://www.oecd-ilibrary.org/
OECD 451 Carcinogenicity Studies
Study Purpose and Introduction:
The objective of a long-term carcinogenicity study is to observe test animals for a major portion of their life span for the development of neoplastic lesions during or after exposure to various doses of a test substance by an appropriate route of administration. The three main routes of administration used in carcinogenicity studies are oral, dermal and inhalation. The choice of the route of administration depends on the physical and chemical characteristics of the test chemical and the predominant route of exposure of humans. The duration of the study will normally be 24 months for rodents.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 451, “Carcinogenicity Studies” (link: https://www.oecd-ilibrary.org/
OECD 452 Chronic Toxicity Studies
Study Purpose and Introduction:
The objective of these chronic toxicity studies is to characterize the profile of a substance in a mammalian species (primarily rodents) following prolonged and repeated exposure. Frequency of exposure normally is daily, but may vary according to the route chosen (oral, dermal or inhalation) and should be adjusted according to the toxicokinetic profile of the test substance. The duration of the exposure period should be 12 months.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 452, “Carcinogenicity Studies” (link: https://www.oecd.org/env/test-no-452-chronic-toxicity-studies-9789264071209-en.htm)
OECD 453 Combined Chronic Toxicity/Carcinogenicity Studies
Study Purpose and Introduction:
The objective of this combined chronic toxicity/carcinogenicity study is to determine the effects of test item following prolonged and repeated oral, dermal or inhalation exposure to rodents in order to determine the carcinogenic potential as well as general chronic toxicity, including neurological, physiological, biochemical, and haematological effects and exposure-related morphological effects. The period of dosing and duration of the study is normally 12 months for the chronic phase, and 24 months for the carcinogenicity phase.
Guidelines and literature:
OECD Guidelines for the Testing of Chemicals, Section 4, No. 453, “Combined Chronic Toxicity/Carcinogenicity Studies” (link: https://www.oecd-ilibrary.org/environment/test-no-453-combined-chronic-toxicity-carcinogenicity-studies_9789264071223-en)